NCT06795412 2026-03-06Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid TumorsPyxis Oncology, IncPhase 1/2 Recruiting220 enrolled
NCT05804526 2024-04-30A Study of RC88 Combined With Sintilimab for Advanced Solid TumoursRemeGen Co., Ltd.Phase 1/2 Recruiting82 enrolled